Literature DB >> 18703023

Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.

Joshua E Muscat1, Brian Pittman, Wayne Kleinman, Philip Lazarus, Steven D Stellman, John P Richie.   

Abstract

The lower incidence rate of transitional cell carcinoma of the urinary bladder in blacks than in whites may be due to racial differences in the catalytic activity of enzymes that metabolize n class="Disease">carcinogenic arylamines in tobacco smoke. To examine this, we compared cytochrome P4501A2 (CYP1A2) and N-acetyltransferase-2 activities (NAT2) in black and white smokers using urinary caffeine metabolites as a probe for enzyme activity in a community-based study of 165 black and 183 white cigarette smokers. The paraxanthine (1,7-dimethylxanthine, 17X)/caffeine (trimethylxanthine, 137X) ratio or [17X+1,7-dimethyluric acid (17U)]/137X ratio was used as an indicator of CYP1A2 activity. The 5-acetyl-amino-6-formylamino-3-methyluracil (AFMU)/1-methylxanthine (1X) ratio indicated NAT2 activity. The odds ratio for the slow NAT2 phenotype associated with black race was 0.4; 95% confidence intervals 0.2-0.7. The putative combined low risk phenotype (slow CYP1A2/rapid NAT2) was more common in blacks than in whites (25% vs. 15%, P<0.02). There were no significant racial differences in slow and rapid CYP1A2 phenotypes, and in the combined slow NAT2/rapid CYP1A2 phenotype. Age, education, cigarette smoking amount, body mass index, GSTM1 and GSTM3 genotypes were unrelated to CYP1A2 and NAT2 activity. Intake of cruciferous vegetables (primarily broccoli), red meat, carrots, grapefruit and onions predicted CYP1A2 activity either for all subjects or in race-specific analyses. Carrot and grapefruit consumption was related to NAT2 activity. Collectively, these results indicated that phenotypic differences in NAT2 alone or in combination with CYP1A2 might help explain the higher incidence rates of transitional cell bladder cancer in whites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703023      PMCID: PMC2597011          DOI: 10.1016/j.bcp.2008.07.024

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  75 in total

1.  Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.

Authors:  H Bartsch; N Caporaso; M Coda; F Kadlubar; C Malaveille; P Skipper; G Talaska; S R Tannenbaum; P Vineis
Journal:  J Natl Cancer Inst       Date:  1990-12-05       Impact factor: 13.506

2.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

Authors:  M A Butler; M Iwasaki; F P Guengerich; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).

Authors:  L H Jeyakumar; U A Arowoshegbe; O O Akinyinka; F O Akinbami; E A Bababunmi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

4.  Acetylator polymorphism in Parkinson's disease.

Authors:  J M Ladero; F J Jimenez; J Benitez; M J Fernandez-Gundin; C Martinez; A Llerena; J Cobaleda; J J Muñoz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Cancer of the urinary bladder in blacks and whites. A case-control study.

Authors:  R E Harris; J Y Chen-Backlund; E L Wynder
Journal:  Cancer       Date:  1990-12-15       Impact factor: 6.860

6.  Acetylator phenotype in relation to age and gender in the Baltimore Longitudinal Study of Aging.

Authors:  M R Korrapati; J D Sorkin; R Andres; D C Muller; C M Loi; E S Vesell; R E Vestal
Journal:  J Clin Pharmacol       Date:  1997-02       Impact factor: 3.126

7.  Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma.

Authors:  V Jahnke; R Strange; C Matthias; A Fryer
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

8.  Validation of a self-administered diet history questionnaire using multiple diet records.

Authors:  G Block; M Woods; A Potosky; C Clifford
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

9.  Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.

Authors:  J P Richie; S G Carmella; J E Muscat; D G Scott; S A Akerkar; S S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-10       Impact factor: 4.254

10.  Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models.

Authors:  M S Driscoll; T M Ludden; D T Casto; L C Littlefield
Journal:  J Pharmacokinet Biopharm       Date:  1989-04
View more
  5 in total

1.  Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Michelle Jankowski; Sheri Trudeau; Andrew Rundle; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2012-10-12       Impact factor: 4.944

2.  Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome.

Authors:  Janice Forster; Jessica Duis; Merlin G Butler
Journal:  Genes (Basel)       Date:  2021-01-24       Impact factor: 4.096

3.  Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis.

Authors:  Mohammad M Al-Ahmad; Naheed Amir; Subramanian Dhanasekaran; Anne John; Yousef M Abdulrazzaq; Bassam R Ali; Salim M A Bastaki
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

Review 4.  Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.

Authors:  Jan Grzegorzewski; Florian Bartsch; Adrian Köller; Matthias König
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

5.  N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.

Authors:  Eleni Aklillu; Juan Antonio Carrillo; Eyasu Makonnen; Leif Bertilsson; Natasa Djordjevic
Journal:  Eur J Clin Pharmacol       Date:  2018-03-27       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.